NCT04427891

Brief Summary

Perforated diverticulitis of the colon can be complicated by peritonitis, either purulent or fecal. Both are life threatening conditions requiring emergency surgery. The background in terms of reasons for inflammation (diverticulitis) and perforation to develop is unknown. In this study we focus on specific changes associated with inflammation, both in tissues and of fecal and mucosal microbiota.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Sep 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Sep 2021Dec 2027

First Submitted

Initial submission to the registry

June 5, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 21, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

4.7 years

First QC Date

June 5, 2020

Last Update Submit

April 22, 2026

Conditions

Keywords

perforated diverticulitisperitonitisprotein changesmicrobiota

Outcome Measures

Primary Outcomes (1)

  • inflammatory response

    determination of levels of 92 proteins in abdominal fluid and blood

    index surgery (Groups I and II)/ emergency room (Group III)

Secondary Outcomes (2)

  • inflammatory response in tissue

    index surgery (Groups I and II)/ emergency room (Group III)

  • microbiota composition

    index surgery (Groups I and II)/ emergency room (Group III)

Study Arms (3)

Group I

Patients undergoing emergency surgery due to perforated diverticulitis with peritonitis. No intervention, samples from abdominal fluid, blood, tissue, feces

Group II

Patients with colorectal cancer undergoing elective surgery. No intervention. Samples as for Group I

Group III

Patients with mild diverticulitis, not undergoing surgery. No intervention. Samples from blood and feces.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The aim is to study immune responses in patients with perforated divrticulitis leading to peritonitis and emergency surgery. This group will be compared with patients operated for colorectal cancer and patients with uncomplicated (mild) diverticulitis not undergoing surgery.

You may qualify if:

  • Signs of perforated diverticulitis with peritonitis and decision to perform emergency surgery (Group I)
  • Signs of acute diverticulitis and no decision of emergency surgery (Group II)
  • Patients with colorectal cancer planned for elective surgery (Group III)

You may not qualify if:

  • No surgery performed (Group I and III)
  • Withdrawn consent (any group)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital/Östra

Gothenburg, Västra Götaland County, SE 416 85, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

periferal blood, abdominal fluid, colon wall, feces

MeSH Terms

Conditions

Peritonitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsPeritoneal DiseasesDigestive System Diseases

Study Officials

  • Eva Haglind, MD,PhD

    Sahlgrenska univesitetssjukhuset

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 11, 2020

Study Start

September 21, 2021

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations